The increase has been driven largely by Quadralene’s expansion in healthcare markets and their products are now sold in 41 countries worldwide. In 2012, overseas sales increased by 70% and are forecast to rise by a further 50% this year.
Managing Director of Dentisan, Andy Corley, said, “I am thrilled to receive this award on behalf of a terrific team that works hard each day to build our growing reputation as a leader in the field of infection control. Their tireless effort on behalf of our international clients is what makes the difference. This award is proof that their work is recognised not only in the UK market but also on a global stage.”
Medilink is an organisation that celebrates the latest technologies, outstanding business achievement and international success across the UK Life Sciences sector and this is not the first Medilink award-win for the company. Two years ago, Dentisan received an “Outstanding Achievement” award for their collaborative work with University of Nottingham School of Biosciences in developing Bioclear, a biofilm remover for Dental Unit Water Lines. The company now goes forward to Medilink’s National Finals, held at the end of the year.
For more details of Dentisan’s full range of infection control products visit www.dentisan.co.uk